Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results
Go back to Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 106.49 +1.14 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $105.35 | 52 Week High | $18.39 | |||
| Open | $104.48 | 52 Week Low | $6.96 | |||
| Day High | $106.94 | P/E | N/A | |||
| Day Low | $103.47 | EPS | $-0.58 | |||
| Volume | 1,280,006 | |||||
